Hepatatox NDC 43857-0543

NDC codes

FDA NDC Directory

Product NDC (as listed)43857-0543Labeler and product segments. Claims need a package NDC.

Product NDC at billing width43857-0543Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
43857-0543-1	43857054301	30 mL in 1 BOTTLE, DROPPER (43857-0543-1)Marketed from Feb 20, 2020

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Hepatatox
Generic name (nonproprietary): triticum aestivum, chelidonium majus, taraxacum officinale, glutathione, hepar suis, thyroidinum (suis), lycopodium clavatum, nux vomica, phosphoricum acidum, adrenocorticotrophin, salicylicum acidum, cortisone aceticum, eugenol, stearyl alcohol, xylitol, folliculinum, benzoicum acidum, chlorinum potassium sorbate, sorbitol, resorcinum, benzyl alcohol, lacticum acidum, isopropyl palmitate, boricum acidum, aceticum acidum, phenyl butazone, petroleum jelly, plumbum metallicum
Active ingredients: Triticum aestivum whole — 1 [hp_X]/mLChelidonium majus whole — 3 [hp_X]/mLTaraxacum officinale — 3 [hp_X]/mLGlutathione — 6 [hp_X]/mLPork liver — 8 [hp_X]/mLThyroid — 8 [hp_X]/mLLycopodium clavatum spore — 12 [hp_X]/mLStrychnos nux-vomica seed — 12 [hp_X]/mLPhosphoric acid — 12 [hp_X]/mLCorticotropin — 30 [hp_C]/mLSalicylic acid — 30 [hp_X]/mLCortisone acetate — 30 [hp_X]/mLEugenol — 30 [hp_X]/mLStearyl alcohol — 30 [hp_X]/mLXylitol — 30 [hp_X]/mLEstrone — 30 [hp_X]/mLBenzoic acid — 30 [hp_X]/mLChlorine — 30 [hp_X]/mLPotassium sorbate — 30 [hp_X]/mLSorbitol — 30 [hp_X]/mLResorcinol — 30 [hp_X]/mLBenzyl alcohol — 30 [hp_X]/mLLactic acid, Dl- — 30 [hp_X]/mLIsopropyl palmitate — 30 [hp_X]/mLBoric acid — 30 [hp_X]/mLAcetic acid — 30 [hp_X]/mLPhenylbutazone — 30 [hp_X]/mLPetrolatum — 30 [hp_X]/mLLead — 30 [hp_X]/mL
Dosage form: Liquid
Route: Oral
Labeler: BioActive Nutritional, Inc
Product type: Over-the-counter drug
Marketing category: Unapproved homeopathic
Marketing start: Feb 20, 2020
Listing expires: Dec 31, 2026
Other FDA classes: Adrenocorticotropic Hormone (Chemical structure)Allergens (Chemical structure)Allergens (Chemical structure)Ammonium Ion Binding Activity (Mechanism)Cell-mediated Immunity (Physiologic effect)Cell-mediated Immunity (Physiologic effect)Corticosteroid Hormone Receptor Agonists (Mechanism)Increased Histamine Release (Physiologic effect)Increased Histamine Release (Physiologic effect)Increased IgG Production (Physiologic effect)Plant Proteins (Chemical structure)Seed Storage Proteins (Chemical structure)
Identifiers: Product ID 43857-0543_7d04c7a1-60d7-41cb-a0b1-dce634a4cae9SPL ID 7d04c7a1-60d7-41cb-a0b1-dce634a4cae9SPL set ID a113a9f1-4792-41a5-8d1b-a6756f356e15UNII 3C3Y389JBU, 7E889U5RNN, 39981FM375, GAN16C9B8O, 6EC706HI7F, 6RV024OAUQ, C88X29Y479, 269XH13919, E4GA8884NN, K0U68Q2TXA, O414PZ4LPZ, 883WKN7W8X, 3T8H1794QW, 2KR89I4H1Y, VCQ006KQ1E, 2DI9HA706A, 8SKN0B0MIM, 4R7X1O2820, 1VPU26JZZ4, 506T60A25R, YUL4LO94HK, LKG8494WBH, 3B8D35Y7S4, 8CRQ2TH63M, R57ZHV85D4, Q40Q9N063P, GN5P7K3T8S, 4T6H12BN9U, 2P299V784P
Pharmacologic class: Adrenocorticotropic Hormone; Corticosteroid; Nitrogen Binding Agent; Non-Standardized Plant Allergenic Extract; Pediculicide; Standardized Chemical Allergen

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N443857054301 followed by a unit qualifier and the quantity

Package 43857-0543-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 18, 2025.

Indications (excerpt from the label)

USES: For temporary relief of dyspepsia, flatulence, exhaustion, and nausea as a consequence of constipation.** **Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)